tetrahydrocortisol has been researched along with Cancer of Endometrium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujimoto, J | 2 |
| Hori, M | 1 |
| Ichigo, S | 2 |
| Tamaya, T | 2 |
| Sakaguchi, H | 1 |
| Hirose, R | 1 |
2 other studies available for tetrahydrocortisol and Cancer of Endometrium
| Article | Year |
|---|---|
Antiestrogenic compounds inhibit estrogen-induced expression of fibroblast growth factor family (FGF-1, 2, and 4) mRNA in well-differentiated endometrial cancer cells.
Topics: Adenocarcinoma; Cell Differentiation; Danazol; Endometrial Neoplasms; Estradiol; Estrogen Antagonist | 1997 |
Progestins suppress estrogen-induced expression of vascular endothelial growth factor (VEGF) subtypes in uterine endometrial cancer cells.
Topics: 17-alpha-Hydroxyprogesterone; Blotting, Southern; Blotting, Western; Dose-Response Relationship, Dru | 1999 |